Visienco AG

Visienco is a Swiss techbio company on a mission to make organoids clinically reliable at scale. Organoids, lab-grown mini-organs, are transforming how we understand human biology and test therapies. But their full potential is limited by manual, variable, and low-throughput workflows. At Visienco, we develop AI-powered lab automation and data tools to unlock this next chapter of organoid-based research. Our first product, the Orgadroid, automates one of the biggest bottlenecks: organoid sorting. It replaces repetitive manual steps with an intelligent system that classifies, selects, and transfers organoids with high precision, improving throughput and reproducibility. Our long-term goal: to enable personalized, data-driven therapies by making organoids a clinically trusted tool.